ABT vs. JNJ: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and JNJ, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
JNJ’s market capitalization of 373.49 billion USD is significantly greater than ABT’s 232.09 billion USD, highlighting its more substantial market valuation.
ABT’s beta of 0.74 points to significantly higher volatility compared to JNJ (beta: 0.41), suggesting ABT has greater potential for both gains and losses relative to market movements.
| Symbol | ABT | JNJ |
|---|---|---|
| Company Name | Abbott Laboratories | Johnson & Johnson |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Drug Manufacturers - General |
| CEO | Mr. Robert B. Ford | Mr. Joaquin Duato |
| Price | 133.4 USD | 155.23 USD |
| Market Cap | 232.09 billion USD | 373.49 billion USD |
| Beta | 0.74 | 0.41 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | January 2, 1943 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and JNJ over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
This section compares the market valuation of ABT and JNJ. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- JNJ’s Forward PEG ratio of 2.70 is very high. This signifies that its current stock price is notably elevated compared to its anticipated earnings growth rate, possibly indicating that the market has already factored in, or even exceeded, realistic future performance expectations.
| Symbol | ABT | JNJ |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.26 | 17.12 |
| Forward PEG Ratio (TTM) | 1.73 | 2.70 |
| Price-to-Sales Ratio (P/S, TTM) | 5.48 | 4.18 |
| Price-to-Book Ratio (P/B, TTM) | 4.78 | 4.78 |
| EV-to-EBITDA (TTM) | 21.32 | 11.16 |
| EV-to-Sales (TTM) | 5.64 | 4.34 |
Dividend Comparison
JNJ provides a dividend yield of 3.23%, which is significantly higher than ABT’s 1.71%, highlighting its commitment to more generous shareholder payouts.
| Symbol | ABT | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 3.23% |
Financial Strength Metrics Comparison
Explore the financial strength details for ABT and JNJ in the table below.
| Symbol | ABT | JNJ |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 1.26 |
| Quick Ratio (TTM) | 1.27 | 1.03 |
| Debt-to-Equity Ratio (TTM) | 0.27 | 0.67 |
| Debt-to-Asset Ratio (TTM) | 0.16 | 0.27 |
| Net Debt-to-EBITDA Ratio (TTM) | 0.60 | 0.40 |
| Interest Coverage Ratio (TTM) | 15.39 | 27.46 |